Sign in Subscribe
Vaccines

New COVID-19 Vaccination Guidelines Limit Access for Millions

Strategic Insights

— 2 min read

U.S. regulators have approved updated COVID-19 vaccines, but with strict limitations that will block access for many Americans. The new guidelines restrict the use of Moderna and Pfizer's vaccines to individuals with at least one high-risk health condition, such as asthma or obesity, and remove Pfizer's vaccine from the market for children under 5. Meanwhile, Novavax's vaccine will only be available for people 12 years or older. The shift in policy reflects skepticism about the ongoing risks of COVID-19 and the need for yearly booster shots, as advocated by Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary.

Key Takeaways:

  • U.S. regulators have approved updated COVID-19 vaccines, but with narrow limitations, restricting use to individuals with high-risk health conditions.
  • Moderna and Pfizer's vaccines are no longer recommended for healthy children and adults under 65, while Novavax's vaccine is only available for people 12 years or older.
  • Parents may still seek out Moderna's Spikevax vaccine, but it is only approved for children with at least one serious health problem.
  • The FDA has revoked the emergency use authorization for Pfizer's vaccine for children under 5, and personal physicians or health professionals will be required to provide the shots "off-label".
  • Insurers and private health providers will need to update their policies and procedures to comply with the new guidelines.
  • Families who want to protect their children may be blocked from getting vaccinated, according to the American Academy of Pediatrics, which recommends annual COVID shots for children aged 6 months to 2 years.
  • Some countries have scaled back COVID-19 vaccinations, but the U.S. has specific logistical challenges, including changes in vaccine coverage decisions and the dissolution of the CDC's vaccine advisory panel.
  • Healthy adults and children who want to get a shot may face difficulties, as they either need to pay out of pocket for the vaccine ($150 or more), or find a doctor or pharmacist willing to give the shot "off-label".
  • The updated vaccines target a newer version of the continuously evolving virus and are set to begin shipping immediately.

Statistics:

  • Nearly all Americans have some protection from previous vaccination or infection.
  • Preliminary data from the CDC estimates 47,500 Americans died from COVID-related causes last year, with COVID-19 listed as the underlying cause of death in at least two-thirds of those cases.
  • The three revised vaccines target a coronavirus subtype named LP.8.1, a recently dominant version of the virus that is closely related to some newly emerging cousins.
  • Moderna received full FDA approval in July for children down to 6 months, but said it will have enough supply to meet U.S. demand.

Sources:

  • AP Medical Writer Lauran Neergaard
  • The Associated Press Health and Science Department
  • Howard Hughes Medical Institute's Science and Educational Media Group
  • The Robert Wood Johnson Foundation
  • The American Academy of Pediatrics
  • CDC (Centers for Disease Control and Prevention)
  • FDA (Food and Drug Administration)

Read more